In the case of certain types of malignant neoplasms, such as Hodgkin’s lymphoma, melanoma, breast cancer and hepatocellular carcinoma, higher numbers of double-positive CD4+CD8+ T cells have been found. This evidence concerns the gene CD8A and breast carcinoma.